Universal Beteiligungs und Servicegesellschaft mbH Purchases 9,933 Shares of Waters Corporation $WAT

Universal Beteiligungs und Servicegesellschaft mbH raised its position in shares of Waters Corporation (NYSE:WAT) by 14.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 79,146 shares of the medical instruments supplier’s stock after buying an additional 9,933 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH owned about 0.13% of Waters worth $27,625,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Zions Bancorporation National Association UT bought a new stake in Waters during the first quarter worth about $28,000. IFP Advisors Inc boosted its position in shares of Waters by 118.9% in the 1st quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier’s stock worth $30,000 after purchasing an additional 44 shares in the last quarter. Caitong International Asset Management Co. Ltd bought a new stake in shares of Waters in the 1st quarter worth approximately $41,000. Creative Financial Designs Inc. ADV grew its stake in shares of Waters by 533.3% in the 2nd quarter. Creative Financial Designs Inc. ADV now owns 190 shares of the medical instruments supplier’s stock worth $66,000 after buying an additional 160 shares during the last quarter. Finally, Steph & Co. purchased a new position in Waters during the second quarter valued at $73,000. 94.01% of the stock is owned by hedge funds and other institutional investors.

Waters Stock Performance

Shares of WAT opened at $378.31 on Tuesday. The firm has a market capitalization of $22.52 billion, a P/E ratio of 34.11, a PEG ratio of 3.19 and a beta of 1.11. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.75 and a quick ratio of 1.22. Waters Corporation has a one year low of $275.05 and a one year high of $423.56. The business has a fifty day moving average of $333.23 and a 200 day moving average of $327.70.

Waters (NYSE:WAT) last issued its quarterly earnings data on Thursday, May 19th. The medical instruments supplier reported $2.29 earnings per share for the quarter. The firm had revenue of $608.55 million for the quarter. Waters had a net margin of 21.71% and a return on equity of 38.60%. As a group, sell-side analysts anticipate that Waters Corporation will post 12.86 EPS for the current year.

Wall Street Analyst Weigh In

WAT has been the topic of a number of analyst reports. Weiss Ratings reiterated a “hold (c)” rating on shares of Waters in a research note on Wednesday, October 8th. Cowen reiterated a “hold” rating on shares of Waters in a report on Wednesday, November 5th. Deutsche Bank Aktiengesellschaft set a $315.00 price objective on shares of Waters and gave the stock a “hold” rating in a report on Tuesday, August 5th. Jefferies Financial Group set a $385.00 target price on Waters and gave the company a “buy” rating in a research note on Monday, August 4th. Finally, Rothschild Redb upgraded Waters to a “strong-buy” rating in a research note on Wednesday, October 8th. Two investment analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $381.57.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.